Company profile: Groupe Carso
1.1 - Company Overview
Company description
- Provider of environmental and agrifood analytical services, including testing of water and environmental elements (soils, waste, biomass, emissions, air quality), food and animal nutrition sampling and analyses, industrial hygiene and building health services (chemical risk, pollutant concentrations, radioprotection), forensic analyses (genetic/digital fingerprinting, blood trace, electronic/computer evidence), high-throughput DNA sequencing, and lab outsourcing support.
Products and services
- Agroalimentaire: Delivers laboratory-scale services spanning sampling, nutritional profiling, microbiological assays, contaminant testing, and advisory programs for food and animal nutrition
- Eau - Environnement: Supplies environmental analytics for consumption, leisure, surface, underground, and residual waters, plus soils, waste, biomass, emissions, and air quality, with high-resolution mass spectrometry for dioxins
- Hygiène industrielle et santé du bâtiment: Offers occupational-grade programs for chemical risk assessment, quantitative pollutant concentration determination, and radioprotection to safeguard industrial workplaces and building health.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Groupe Carso
Newport Labs
HQ: United States
Website
- Description: Provider of veterinary healthcare services and high-quality autogenous biologics for the livestock industry, applying 21st technology to a traditional autogenous approach to formulate products that pinpoint specific disease problems, supported by dedicated employees and innovative solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newport Labs company profile →
Intelligent BioSystems
HQ: United States
Website
- Description: Provider of an advanced DNA sequencing system, focused on commercialization. Founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju, the company builds on Dr. Gordon’s prior role founding Intelligent Automation Systems, which delivered key instrumentation solutions that helped complete the Human Genome Project.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent BioSystems company profile →
Isolere Bio
HQ: United States
Website
- Description: Provider of biotherapeutic purification solutions, offering IsoTag Reagent Technology that combines phase separation with affinity ligands to purify biologics, IsoTag AAV for downstream purification of AAV serotypes, IsoTag LV for capturing and concentrating lentivirus, custom development of tailored purification solutions, and pipeline programs for adenovirus, mRNA, and pDNA purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isolere Bio company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
Nextal Biotech
HQ: United States
Website
- Description: Provider of products designed for experimental crystallization needs, offering plates with grease-free, independent, screwable crystallization supports.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nextal Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Groupe Carso
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Groupe Carso
2.2 - Growth funds investing in similar companies to Groupe Carso
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Groupe Carso
4.2 - Public trading comparable groups for Groupe Carso
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →